Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector

Dardalhon, V.; Jaleco, S.; Rebouissou, C.; Ferrand, C.; Skander, N.; Swainson, L.; Tiberghien, P.; Spits, H.; Noraz, N.; Taylor, N.


2000-08-01 / vol 96 / pages 885-93


Retroviral vectors based on the Moloney murine leukemia virus (MuLV) have become the primary tool for gene delivery into hematopoietic cells, but clinical trials have been hampered by low transduction efficiencies. Recently, we and others have shown that gene transfer of MuLV-based vectors into T cells can be significantly augmented using a fibronectin-facilitated protocol. Nevertheless, the relative abilities of naive (CD45RA(+)) and memory (CD45RO(+)) lymphocyte subsets to be transduced has not been assessed. Although naive T cells demonstrate a restricted cytokine profile following antigen stimulation and a decreased susceptibility to infection with human immunodeficiency virus, it was not clear whether they could be efficiently infected with a MuLV vector. This study describes conditions that permitted gene transfer of an enhanced green fluorescent protein-expressing retroviral vector in more than 50% of naive umbilical cord (UC) blood and peripheral blood (PB) T cells following CD3/CD28 ligation. Moreover, treatment of naive T cells with interleukin-7 resulted in the maintenance of a CD45RA phenotype and gene transfer levels approached 20%. Finally, it was determined that parameters for optimal transduction of CD45RA(+) T cells isolated from PB and UC blood differed: transduction of the UC cells was significantly increased by the presence of autologous mononuclear cells (24.5% versus 56.5%). Because naive T cells harbor a receptor repertoire that allows them to respond to novel antigens, the development of protocols targeting their transduction is crucial for gene therapy applications. This approach will also allow the functions of exogenous genes to be evaluated in primary nontransformed naive T cells.

Lire sur PubMed


Humans; *Gene Transfer Techniques; Lymphocyte Activation; Immunophenotyping; Genes, Reporter; Green Fluorescent Proteins; *Genetic Vectors; *Leukemia Virus, Murine; Luminescent Proteins; T-Lymphocyte Subsets/*physiology

Toutes les publications